Verdence Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.36M | Buy |
49,521
+792
| +2% | +$92.7K | 0.33% | 67 |
|
|
2026
Q1 | $5.86M | Buy |
48,729
+2,280
| +5% | +$263K | 0.34% | 58 |
|
|
2025
Q4 | $4.89M | Buy |
46,449
+4,393
| +10% | +$412K | 0.29% | 77 |
|
|
2025
Q3 | $3.7M | Buy |
42,056
+308
| +0.7% | +$25.4K | 0.21% | 115 |
|
|
2025
Q2 | $3.3M | Sell |
41,748
-4,228
| -9% | -$336K | 0.23% | 106 |
|
|
2025
Q1 | $4.13M | Sell |
45,976
-1,215
| -3% | -$113K | 0.32% | 76 |
|
|
2024
Q4 | $4.69M | Sell |
47,191
-8,888
| -16% | -$916K | 0.38% | 62 |
|
|
2024
Q3 | $6.37M | Buy |
56,079
+1,231
| +2% | +$146K | 0.51% | 46 |
|
|
2024
Q2 | $6.79M | Buy |
54,848
+1,120
| +2% | +$144K | 0.6% | 37 |
|
|
2024
Q1 | $7.09M | Buy |
53,728
+12
| +0% | +$1.48K | 0.65% | 35 |
|
|
2023
Q4 | $5.86M | Sell |
53,716
-22
| -0% | -$2.28K | 0.57% | 41 |
|
|
2023
Q3 | $5.53M | Buy |
53,738
+3,348
| +7% | +$361K | 0.6% | 40 |
|
|
2023
Q2 | $5.81M | Sell |
50,390
-15
| -0% | -$1.7K | 0.68% | 35 |
|
|
2023
Q1 | $5.36M | Sell |
50,405
-5,216
| -9% | -$563K | 0.65% | 36 |
|
|
2022
Q4 | $6.17M | Sell |
55,621
-2,843
| -5% | -$291K | 0.76% | 25 |
|
|
2022
Q3 | $5.04M | Sell |
58,464
-1,166
| -2% | -$104K | 0.69% | 29 |
|
|
2022
Q2 | $5.44M | Sell |
59,630
-8,243
| -12% | -$731K | 0.7% | 28 |
|
|
2022
Q1 | $5.57M | Sell |
67,873
-27,345
| -29% | -$2.16M | 0.63% | 35 |
|
|
2021
Q4 | $7.3M | Sell |
95,218
-11,251
| -11% | -$896K | 0.86% | 21 |
|
|
2021
Q3 | $8M | Buy |
106,469
+11,915
| +13% | +$906K | 1.05% | 16 |
|
|
2021
Q2 | $7.35M | Buy |
94,554
+29,985
| +46% | +$2.23M | 1.02% | 16 |
|
|
2021
Q1 | $4.75M | Buy |
64,569
+1,589
| +3% | +$117K | 0.8% | 27 |
|
|
2020
Q4 | $4.92M | Buy |
62,980
+13,657
| +28% | +$1.04M | 0.93% | 20 |
|
|
2020
Q3 | $3.9M | Buy |
49,323
+807
| +2% | +$63.2K | 0.89% | 24 |
|
|
2020
Q2 | $3.58M | Buy |
48,516
+6,504
| +15% | +$490K | 0.88% | 27 |
|
|
2020
Q1 | $3.08M | Buy |
42,012
+6,692
| +19% | +$526K | 0.92% | 27 |
|
|
2019
Q4 | $3.06M | Buy |
35,320
+443
| +1% | +$36.4K | 0.75% | 34 |
|
|
2019
Q3 | $2.8M | Sell |
34,877
-818
| -2% | -$65.6K | 0.79% | 34 |
|
|
2019
Q2 | $2.86M | Sell |
35,695
-8,189
| -19% | -$627K | 0.82% | 31 |
|
|
2019
Q1 | $3.48M | Sell |
43,884
-5,984
| -12% | -$448K | 0.94% | 29 |
|
|
2018
Q4 | $3.64M | Sell |
49,868
-689
| -1% | -$48.6K | 1.02% | 26 |
|
|
2018
Q3 | $3.42M | Buy |
50,557
+39,607
| +362% | +$2.52M | 0.85% | 32 |
|
|
2018
Q2 | $634K | Sell |
10,950
-17,514
| -62% | -$988K | 0.15% | 150 |
|
|
2018
Q1 | $1.48M | Buy |
28,464
+4,076
| +17% | +$220K | 0.36% | 66 |
|
|
2017
Q4 | $1.31M | Buy |
+24,388
| New | +$1.35M | 0.31% | 68 |
|
Other funds holding MRK
ECSS
ATO
Verdence Capital Advisors's MRK Position: Q2 2026 in Review
Verdence Capital Advisors increased its Merck (MRK) stake by 1.6% in Q2 2026, buying an estimated $92.7K and bringing the position to 49,521 shares worth $6.36M. The position accounts for 0.33% of the portfolio, ranked #67.
Verdence Capital Advisors first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $8M in Q3 2021. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Verdence Capital Advisors held 49,521 shares of Merck worth $6.36M as of Q2 2026.
- Verdence Capital Advisors bought 792 Merck shares in Q2 2026, an estimated $92.7K.
- Merck made up 0.33% of Verdence Capital Advisors's portfolio in Q2 2026, its #67 holding.
- Verdence Capital Advisors first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Verdence Capital Advisors's Merck position peaked at $8M in Q3 2021.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Verdence Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.